Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract presentation on...

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today issued the following statement in...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2025 and recent business highlights.

Eventgroove is proud to share that the company has been recognized as the 2025 Exporter of the Year for the Rocky Mountain Region by the SBA.

Dr. Edward Robb, Chief Strategy Officer, Anivive Lifesciences presented their pioneering research update on Valley Fever at the World Vaccine Congress 2025 in Washington, D.C. His talk, titled "A Double-Edged Sword:...

Palatin Technologies, Inc. (OTC PINK: PTNT), a biopharmaceutical company advancing innovative treatments targeting the melanocortin receptor system, today announced new preclinical data on its melanocortin agonists PL9654...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that one abstract on izalontamab brengitecan (iza-bren), a potentially first-in-class EGFRxHER3 bispecific antibody drug conjugate...

Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ("Qilu") for the development, manufacturing,...

Many deaf children in Laos are unable to attend school due to discrimination, shortage of qualified teachers trained in deaf education or sign language, and an inability to pay school fees. Hands of Hope School for the...

Palatin Technologies, Inc. (OTC PINK: PTNT) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system,...

Envision Energy, a global leader in green technology,  released its 2025 Net Zero Action Report at the Smarter E Europe in Munich, reaffirming its commitment to climate leadership. The company achieved operational carbon...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the...

Palatin Technologies, Inc. (OTC PINK: PTNT), a biopharmaceutical company advancing innovative treatments targeting the melanocortin receptor system, today presented new data from the Phase 3 MELODY-1 study at the 2025...

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, is announcing corrected call-in...

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2025.

Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations to target...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, today announced financial...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™) to profoundly improve people's lives,...

The Sarcoma Alliance for Research through Collaboration (SARC) is proud to announce the re-launch of a significantly enhanced SARC Sarcoma Centers Directory (SCD, https://sarctrials.org/sarcoma-centers). The SCD serves as...

ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding...

BioWell, a Houston-based nonprofit accelerator for industrial biomanufacturing founded by First Bight Ventures, has officially assumed operations of Texas BioTechnology's pilot plant in Richmond, TX. The facility...

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies (Optieum), a preclinical stage company dedicated to the discovery and development of...

DNV, the independent assurance and risk management provider, has been recognized by the European Commission as a notified body for the certification of devices under the European Union's In Vitro Diagnostic Regulation...

In a groundbreaking collaboration, Phosphorex, NOF CORPORATION, NeoSome Life Sciences, NanoImaging Services (NIS), and Envol Biomedical have joined forces to establish the LNP Alliance, a strategic partnership dedicated to...

A survey released today from the Alliance for mRNA Medicines warns that cuts to biomedical research and threats of anti-mRNA policies risk delays to therapeutic advances in cancer, rare diseases, and other diseases, loss...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the third patient in Cohort 4 of its Phase 1a clinical trial...

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced that it entered into an...

Company continues to explore and review strategic options focused on maximizing shareholder value

Peptone, a biotech company developing novel therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases, today announced a partnership with Evotec to accelerate and scale the creation of small...

Viatris Inc. (Nasdaq: VTRS) today reported first quarter 2025 financial results and reaffirmed its 2025 outlook[1].

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Eric Matthews has joined the organization as Chief Business Officer, Biopharma Business...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive results from its Phase 3 program of the novel fast-acting formulation of meloxicam (MR-107A-02) for the treatment of moderate-to-severe...

NextGen Jane, a women's health company that is developing menstrual diagnostics for gynecological care, announced that it has received a SBIR Direct to Phase II grant from the Eunice Kennedy Shriver National Institute...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches to precision T cell activation, today announced that the first patient has been dosed in its STARt-002 clinical trial. The...

Hyundai Bioscience presented the results of its Penetrium™ combination preclinical studies at the 2025 American Association for Cancer Research (AACR) Annual Meeting, held in Chicago.

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from its Phase 1 trial...

Palatin Technologies, Inc. ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines targeting the melanocortin receptor system, today announced that it has received a notice from the...

Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical need, today announced...

SOURCE THE ROSEN LAW FIRM, P. A. NEW YORK, May 7, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2025 lead plaintiff deadline. So what: If you purchased S...

MicroTransponder®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim® Paired VNS™ System for chronic stroke recovery, today announced the publication of new findings in the peer...

TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable disease, today announced that Merigolix (code name:...

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today issued the following statement in...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025.

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced the presentation of end-of-treatment (EOT) clinical data from its ongoing Phase IIb...

Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, will showcase significant regulatory, preclinical, and CMC advancements across several oral and poster presentations at the 28th...

Aspen Neuroscience has released 6-month data from the first three patients dosed in the ASPIRO Phase 1/2a trial of ANPD001, an investigational autologous dopaminergic neuronal precursor cell (DANPC) therapy being studied...

IDBS, a leading global provider of cloud software for BioPharma companies, has shared compelling results from its latest survey into the current challenges and future priorities for lab data management in the...

TORONTO, May 7, 2025 /PRNewswire/ - Geneseeq Technology Inc., in collaboration with leading clinical institutions, has developed a cutting-edge blood-based screening test that could transform early detection of pancreatic...

Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with the launch of a new bronchoalveolar lavage (BAL) specimen type for...

Inari, the SEEDesign™ company, appointed long-time agriculture industry leader Lisa Nunez Safarian to its board of directors, effective May 1, 2025.

The Stephen M. Ross School of Business Executive Education at the University of Michigan, in collaboration with Emeritus, has launched the Board Director Program. This five-month immersive program is uniquely designed to...

Hanx Biopharmaceuticals Ltd. (HanxBio), a clinical-stage biotechnology company pioneering next-generation immunotherapies, highlighted its expanding oncology and autoimmune disease pipeline with five research poster...

Alafair Biosciences, Inc., a leading innovator in hydrogel technology for medical applications, is proud to announce its selection to the 2025 Longhorn 100, a prestigious list recognizing the fastest-growing businesses led...

Infinant Health, a privately-held company focused on changing the trajectory of human health - one baby at a time - announced today that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation...

Altesa BioSciences today announced positive topline results from its Phase 2 placebo-controlled study examining the effects of vapendavir in COPD patients challenged with rhinovirus.  In this study, treatment with...

Amplifica Holdings Group Inc. ("Amplifica"), a privately held clinical-stage biopharmaceutical company, today announced the poster presentation of positive results from its first-in-human trial of AMP-303, a...

Connext, a clinical stage biotechnology company, announced the successful completion of the dose escalation (Phase 1) part of its Phase 1/2 clinical trial for CNT201, its recombinant collagenase therapeutic for...

Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, today announced that the company will present results from two recent clinical trials at the...

Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has licensed ATUM's proprietary Leap-In Transposase®...

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi Advanced Therapies have been combined to form Minaris Advanced...

Palatin Technologies, Inc. (the "Company" or "Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor...

Aspen Neuroscience scientists, led by Chief Scientific Officer Xiaokui Zhang, Ph.D., will present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting, held this week May 7-10 at the Ernest N....

CAMBRIDGE, Mass., May 7, 2025 /PRNewswire/ – Invaio Sciences, a leading bioplatform company founded by Flagship Pioneering and accelerating the transition to nature-positive agriculture, today announced the appointment of...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA) (OTC: SNANF) ("Sona") announce today that they have entered into a Research Agreement ("Agreement") to...

Report shares firm's continued progress toward generating long-term value for its business, customers, communities, and shareholders

Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor...

Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference.

ViVerita Therapeutics ("ViVerita"), a US-based next-generation precision oncology company, today announced a strategic research collaboration with Boehringer Ingelheim aimed at accelerating the discovery and validation of...

PAQ Therapeutics, a biotechnology company developing best- and first-in-class KRAS degraders for lethal cancers lacking effective treatment options, today announced that Andrew Krivoshik, MD, PhD, has joined the company as...

PAQ Therapeutics, a biotechnology company developing best- and first-in-class KRAS degraders for patients with lethal cancers lacking effective treatment options, today announced the completion of its $39 million Series B...

Inductive Bio, a technology company democratizing artificial intelligence (AI) models to transform small molecule drug discovery, announced today that it has raised $25M in Series A financing led by Obvious Ventures with...

Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend...

Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025.

Gardin is growing their list of customers leveraging their novel optical photosynthesis sensor & AI that measures crop photosynthesis in real time, giving growers early insight into plant health and development. This...

Grand Pharmaceutical Group Limited (0512.HK, "Grand Pharma" or the "Group") announces that the Phase II clinical study for the treatment of sepsis in China of the global innovative drug STC3141, which is independently...

CIMC Modular Building Systems (CIMC MBS), a global leader in advanced modular construction, has earned two prestigious awards at the 2025 World of Modular Conference, organized by the Modular Building Institute (MBI). The...

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific...

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the U.S. Food and...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved...

Perfuse Therapeutics, Inc. ("Perfuse Therapeutics"), a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, today announced positive 24-week results from its completed...

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the first quarter ended March 31, 2025. The update,...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for the...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the first quarter ended March 31, 2025, including sales...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in May.

Plasmidsaurus, the company that sequences while you sleep, today announced the opening of its tenth global sequencing lab, located in Singapore's vibrant biomedical hub. The new site dramatically shortens turnaround...

Paradigm Therapeutics, Inc., a biopharmaceutical company, announces a $12.5 Million investment by Eshelman Ventures, LLC and appointment of Dr. Eshelman as a strategic advisor for Paradigm. SD-101 (Zorblisa™) is being...

TORONTO, May 6, 2025 /PRNewswire/ - Specific Biologics Inc., a biotechnology company advancing industry leading genome editing therapies, today announced it will present new preclinical data at the 28th Annual Meeting of...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, today announced that Daniel Galbraith, PhD, Chief Scientific Officer, will be speaking at the American Society of Cell and Gene Therapy...

Prometheus Hyperscale ("Prometheus"), a leading developer of sustainable hyperscale data centers, PureWest Energy, LLC ("PureWest"), Wyoming's largest natural gas producer, and Frontier Carbon Solutions, LLC...

Helio Genomics ("Helio" or "the Company"), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today showcased results from three cancer detection studies at...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will...

Volta Labs, Inc., a leading genomics applications company, and Hartwig Medical Foundation, a global pioneer in genomics-driven oncology research and clinical care, today announced a multi-year collaboration aimed at...

GRIN Therapeutics, Inc., a leader in the development of therapies to treat serious neurodevelopmental disorders, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and financial results for the...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has been selected for the Korea Disease Control and Prevention Agency...